Insider Trading History of Meyers Peter A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Meyers Peter A. since 2013. The trader's CIK number is 1590862. At the time of the last reporting, Meyers Peter A. was the CFO & Treasurer of Eagle Pharmaceuticals, Inc.. (stock ticker symbol EGRX). Also see all insider trading activities at Eagle Pharmaceuticals, Inc..

Note that in the past Meyers Peter A. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eagle Pharmaceuticals, Inc. (EGRX) by Meyers Peter A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 EGRX 700 $44,426 0 $0 0 $0

Yearly summary of insider trading at Tetralogic Pharmaceuticals Corp (TLOG) by Meyers Peter A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 TLOG 5,000 $21,750 0 $0 0 $0
2014 TLOG 6,034 $24,997 0 $0 0 $0
2013 TLOG 142,857 $999,999 0 $0 0 $0


Insider trading activities at 2 companies by Meyers Peter A.:

1. Eagle Pharmaceuticals, Inc. (EGRX)

2. Tetralogic Pharmaceuticals Corp (TLOG)

Table 1. Insider trading of Eagle Pharmaceuticals, Inc. (EGRX) by Meyers Peter A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-08-16 EGRX Buy 350 55.45 19,406
2017-06-12 EGRX Buy 350 71.49 25,020

Table 2. Insider trading of Tetralogic Pharmaceuticals Corp (TLOG) by Meyers Peter A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-03-27 TLOG Buy 5,000 4.35 21,750
2014-12-04 TLOG Buy 1,034 4.94 5,107
2014-11-12 TLOG Buy 5,000 3.98 19,890
2013-12-17 TLOG Buy 142,857 7.00 999,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meyers Peter A. (CFO & Treasurer of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.